EXPERIENCE OF ABROCITINIB IN ATOPIC DERMATITIS-Reference-Cited by-同舟云学术

EXPERIENCE OF ABROCITINIB IN ATOPIC DERMATITIS

Published:2024-09-08 Issue: Volume: Page:
ISSN:2412-9097
Container-title:Russian Journal of Skin and Venereal Diseases
language:
Short-container-title:Russian Journal of Skin and Venereal Diseases

Author:

Abdulridha ALI Hussein¹^ORCID,Olisova Olga Yu.²^ORCID,Kochergin Nikolay G.²^ORCID,Myzina Kristina Alexandrovna,³^ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

2. I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

3. I.M. Sechenov First Moscow State Medical University (Sechenov University)

Abstract

Atopic dermatitis is an autoinflammatory, genetically determined, itchy disease characterized by a long, relapsing course and a sharp decrease in the patient’s quality of life. Atopic dermatitis (AD) is caused by a complex interaction of immune dysregulation, epidermal gene mutations, and multi-environmental factors that affect the skin, causing intense itchy rashes. The disease often occurs among young children and subsequently has age-related clinical features. Currently, the treatment of atopic dermatitis has a wide range of options, including drugs from the group of small molecules recently registered in the Russian Federation. The first clinical experience with the use of abrocitinib in adult patients with atopic dermatitis is presented.

Publisher

ECO-Vector LLC

Reference26 articles.

1. Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection

2. Kochergin N.G. Skin barrier, xerosis and rosacea. Russian Allergological Journal. 2013;6:9-12.

3. Pobezhimova O.O., Zhestkov A.V., Sidorova O.S. et al. Features of immunopathogenesis of atopic dermatitis. Russian Allergological Journal. 2020. T. 17. № 2. S. 74-80.

4. Migacheva N.B. Atopic dermatitis: an expert review of clinical recommendations. Eurasian Scientific Association. 021. № 9-2 (79). С. 109-113.

5. Kelexsaeva A.A. Atopic dermatitis. Classification and treatment methods. Trends in the development of science and education. 2023. № 96-7. С. 24-27.